Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 45865-184

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 45865-184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

184 (45865 184)

Tramadol HCL ER Tablets 300 mg extended-release oral tablets generic for Ultram ER. The label shows a white, round tablet unit, manufactured by Lupin Limited in Pithampur, India, packaged 30 tablets per bottle. The label includes dosing instructions with blanks and warnings about dizziness and avoiding alcohol. Distributed by Medsource Pharmaceuticals.*

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

Chemical structure of Tramadol Hydrochloride showing the molecular arrangement of atoms including methoxyphenyl, cyclohexanol, and dimethylamino groups with the hydrochloride component.*

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

A line graph depicting Tramadol concentration (ng/mL) over 24 hours comparing two dosage forms: Tramadol Hydrochloride Extended-Release Tablets, 200 mg once daily, and Tramadol Hydrochloride Tablets, 50 mg every 6 hours. The graph shows fluctuations in plasma levels for both formulations across the time points.*

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

A line graph comparing M1 metabolite concentration (ng/mL) over 24 hours between Tramadol Hydrochloride Extended-Release Tablets 200 mg taken once daily (q.d.) and Tramadol Hydrochloride Tablets 50 mg taken every 6 hours (q6h). The x-axis shows time in hours, and the y-axis indicates M1 concentration.*

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

A line graph showing the percentage of patients achieving various response thresholds in a study of Tramadol Hydrochloride Extended-Release Tablets at doses of 100 mg, 200 mg, 300 mg, and 400 mg compared to placebo. The x-axis represents response threshold as percent improvement from baseline, and the y-axis represents the percent of patients achieving the response.*

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

A line graph showing arthritis pain intensity VAS responder analysis from a study on Tramadol Hydrochloride Extended-Release Tablets. The x-axis represents response threshold as percent improvement from baseline (0% to 100%), and the y-axis shows the percent of patients achieving response. Two lines compare Tramadol Hydrochloride Extended-Release Tablets and placebo, with Tramadol consistently showing higher patient response percentages across thresholds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.